Medical cannabis in Australia: Patient benefits and trial results

Recent studies and clinical trials in Australia highlight both the potential benefits and the significant hurdles facing medical cannabis patients. A qualitative study published in the Australian Journal of Primary Health involving long-term users found that patients frequently use medical cannabis oil to manage chronic pain, insomnia, anxiety, and depression. Participants reported that the treatment often allowed them to reduce or replace conventional medications and improved their overall productivity and mental health. However, patients identified high costs, difficulties obtaining prescriptions, and concerns regarding roadside drug testing as major barriers to access.

In a separate development, a clinical trial for an Australian-made CBD tablet developed by TCANN yielded mixed results. While the trial of 155 participants found the tablet to be safe and noted that some users experienced immediate improvement, the product failed to outperform a placebo in meeting the trial's primary goals. The company is currently seeking registration with the Therapeutic Goods Administration (TGA) and intends to investigate the results further to refine the development of non-THC cannabis products for chronic pain management.